Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
We contrast TRI with price indices, highlighting dividends, corporate actions, and reinvestment assumptions that shape different performance pictures.
24,487 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
When Anthropic faced a backlash over secret censorship in Claude Fable 5, the company apologized and promised safegua...
Famed investor Michael Burry considered betting against SpaceX after its IPO but ultimately stayed neutral. The stock...
A dramatic daily swing has SpaceX briefly tumbling below Amazon in market cap. Here's how to judge which growth stock...
Retirees are watching for the social security's 2027 cola, but forecasts recently shifted toward a smaller bump. This...
As mortgage costs stay elevated, distressed properties—short sales and REOs—are quietly widening access to homeowners...
Bitcoin and Ethereum cling to crucial support as Congress prepares to grill the Clarity Act. July eyes are on a poten...
Kinross Gold posted a solid Q4 print after the bell, beating expectations with $0.67 in adjusted EPS and outlining 20...
Aggressive investors chase big upside, and sofi's next breakout: leveraged exposure promises amplified moves. This gu...
A widely followed crypto trader called Cardano ADA one of his worst investments, igniting a cross-community debate ab...
Bitcoin staged a striking break from a long-standing pattern, defying a rising dollar as ETF inflows surged. Analysts...
Goldman Sachs now puts a one-year recession probability at about 25%. Here’s how that signal, plus energy volatility ...